Chemotherapy and the Kidneys: Cisplatin-Induced Nephrotoxicity Prevention


The Short Answer: Cisplatin is a powerful and widely used chemotherapy drug, but it carries a well-known risk of causing nephrotoxicity—meaning it can temporarily or sometimes permanently injure the kidneys. Fortunately, standard clinical protocols heavily focus on prevention. By utilizing aggressive intravenous hydration, careful monitoring of kidney function, and protective medications, oncology and nephrology teams can significantly lower the risk of kidney injury without sacrificing cancer treatment goals.


What This Means

When a medication is described as nephrotoxic, it means it has the potential to harm the structures or filtering efficiency of the kidneys.

Cisplatin enters the kidney cells responsible for filtering waste and balancing water and salts. Once inside, it can trigger inflammation, cellular stress, and cell death. This can result in acute kidney injury (AKI)—a sudden decline in kidney function that shows up as rising creatinine levels or a falling eGFR (an estimate of how well your kidneys filter blood).

However, experiencing a change in kidney labs during chemotherapy does not automatically mean permanent destruction, nor does it mean treatment must be abandoned blindly.


Why Prevention Protocols Work

Because cisplatin’s effects on the kidneys are dose-dependent and cumulative, modern oncology care relies on strict preventive strategies:

  • Aggressive IV Hydration: Flushing the kidneys with intravenous fluids before and after cisplatin administration dilutes the concentration of the drug passing through the renal tubules, drastically reducing its cellular toxicity.
  • Electrolyte Management: Cisplatin frequently causes the body to lose vital minerals like magnesium and potassium. Replacing these electrolytes proactively helps maintain normal cellular stability and protects kidney function.
  • Dose Adjustments and Timing: Oncologists carefully calculate dosages based on body surface area and baseline kidney function, spacing out treatments to give the kidneys time to recover between cycles.
See also  ACE Inhibitors vs ARBs in CKD: How Lisinopril and Losartan Protect Glomerular Pressure

What Lab Results Can and Cannot Tell You

Monitoring lab values—such as serum creatinine, BUN, and eGFR—is essential during chemotherapy, but numbers require careful clinical interpretation:

  • They track acute changes: A sudden jump in creatinine signals that the kidneys are struggling under current stress (AKI), helping care teams pause or adjust treatments immediately.
  • They do not always predict long-term recovery: A temporary dip in kidney function during an intensive round of chemotherapy often improves as hydration and healing take place.
  • Context is vital: Dehydration from nausea, concurrent use of other medications (like NSAIDs or certain antibiotics), and underlying health conditions heavily influence how your kidneys handle chemotherapy.

What You Should Do Next

  • Communicate all medications and supplements: Before starting chemotherapy, give your care team a complete list of everything you take, including over-the-counter painkillers (like ibuprofen or naproxen) and herbal products, which can add extra strain to the kidneys.
  • Stay ahead of hydration: Follow your clinical team’s specific fluid guidelines before and after treatment sessions to support your body’s natural filtering process.
  • Attend all scheduled lab checks: Never skip routine blood work. Tracking your kidney function trends allows your medical team to catch early warning signs and modify your care plan safely.

When to Seek Medical Attention

Contact your oncology clinic or seek urgent medical evaluation if you experience red-flag symptoms during or after chemotherapy, such as:

  • A drastic drop or complete stop in urine output
  • Rapid, noticeable swelling in your legs, ankles, or face
  • Severe nausea and vomiting that prevents you from keeping fluids down
  • Confusion, extreme drowsiness, or severe shortness of breath
See also  Antibiotic Dosage Adjustments in CKD: Aminoglycosides, Vancomycin, and Renal Clearance

The Bottom Line

Cisplatin is an effective cancer-fighting agent that requires careful kidney protection. Through aggressive hydration, meticulous lab tracking, and proactive management by your oncology team, the risk of severe nephrotoxicity can be substantially reduced. Staying informed and communicating closely with your doctors ensures your cancer treatment remains as safe and effective as possible.

Leave a Comment